377 related articles for article (PubMed ID: 28196303)
21. A FUS-LATS1/2 Axis Inhibits Hepatocellular Carcinoma Progression via Activating Hippo Pathway.
Bao L; Yuan L; Li P; Bu Q; Guo A; Zhang H; Cui N; Liu B
Cell Physiol Biochem; 2018; 50(2):437-451. PubMed ID: 30308519
[TBL] [Abstract][Full Text] [Related]
22. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs are differentially expressed in hepatocellular carcinoma cell lines with differing metastatic potential.
Fang TT; Sun XJ; Chen J; Zhao Y; Sun RX; Ren N; Liu BB
Asian Pac J Cancer Prev; 2014; 15(23):10513-24. PubMed ID: 25556502
[TBL] [Abstract][Full Text] [Related]
24. Increased long noncoding RNA LASP1-AS is critical for hepatocellular carcinoma tumorigenesis via upregulating LASP1.
Yin L; Chen Y; Zhou Y; Deng G; Han Y; Guo C; Li Y; Zeng S; Shen H
J Cell Physiol; 2019 Aug; 234(8):13493-13509. PubMed ID: 30677131
[TBL] [Abstract][Full Text] [Related]
25. LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation.
Chen B; Xu X; Wu W; Zheng K; Yu Y
Anal Cell Pathol (Amst); 2023; 2023():5852963. PubMed ID: 37234237
[TBL] [Abstract][Full Text] [Related]
26. A positive feedback loop involving the LINC00346/β-catenin/MYC axis promotes hepatocellular carcinoma development.
Zhang N; Chen X
Cell Oncol (Dordr); 2020 Feb; 43(1):137-153. PubMed ID: 31691159
[TBL] [Abstract][Full Text] [Related]
27. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
[TBL] [Abstract][Full Text] [Related]
28. Silencing of a novel lncRNA LOC105369748 suppresses the progression of hepatocellular carcinoma by sponging miR-5095 from MBD2.
E C; Li C; Li H; Yang J
J Cell Physiol; 2019 Aug; 234(10):18504-18512. PubMed ID: 30912130
[TBL] [Abstract][Full Text] [Related]
29. LINC00460 promotes hepatocellular carcinoma development through sponging miR-485-5p to up-regulate PAK1.
Tu J; Zhao Z; Xu M; Chen M; Weng Q; Ji J
Biomed Pharmacother; 2019 Oct; 118():109213. PubMed ID: 31376654
[TBL] [Abstract][Full Text] [Related]
30. Long noncoding RNA CCAT2 promotes hepatocellular carcinoma proliferation and metastasis through up-regulation of NDRG1.
Liu Y; Wang D; Li Y; Yan S; Dang H; Yue H; Ling J; Chen F; Zhao Y; Gou L; Tang P; Huang A; Tang H
Exp Cell Res; 2019 Jun; 379(1):19-29. PubMed ID: 30922920
[TBL] [Abstract][Full Text] [Related]
31. RNA sequencing reveals the long noncoding RNA and mRNA profiles and identifies long non-coding RNA TSPAN12 as a potential microvascular invasion-related biomarker in hepatocellular carcinoma.
Lu J; Li B; Xiong X; Cheng N
Biomed Pharmacother; 2020 Jun; 126():110111. PubMed ID: 32222644
[TBL] [Abstract][Full Text] [Related]
32. The Emerging Role of Long Non-Coding RNAs in the Metastasis of Hepatocellular Carcinoma.
Chen X; Tang FR; Arfuso F; Cai WQ; Ma Z; Yang J; Sethi G
Biomolecules; 2019 Dec; 10(1):. PubMed ID: 31906046
[TBL] [Abstract][Full Text] [Related]
33. LncRNA MAGI2-AS3 inhibits hepatocellular carcinoma cell proliferation and migration by targeting the miR-374b-5p/SMG1 signaling pathway.
Yin Z; Ma T; Yan J; Shi N; Zhang C; Lu X; Hou B; Jian Z
J Cell Physiol; 2019 Aug; 234(10):18825-18836. PubMed ID: 30924168
[TBL] [Abstract][Full Text] [Related]
34. Long non‑coding RNA AB019562 promotes cell proliferation and metastasis in human hepatocellular carcinoma.
Wu F; Li J; Du X; Zhang W; Lei P; Zhang Q
Mol Med Rep; 2017 Jul; 16(1):69-74. PubMed ID: 28534955
[TBL] [Abstract][Full Text] [Related]
35. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
36. HOX Antisense lincRNA HOXA-AS2 Promotes Tumorigenesis of Hepatocellular Carcinoma.
Wang F; Yang H; Deng Z; Su Y; Fang Q; Yin Z
Cell Physiol Biochem; 2016; 40(1-2):287-296. PubMed ID: 27855366
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of LncDQ is Associated with Poor Prognosis and Promotes Tumor Progression via Epigenetic Regulation of the EMT Pathway in HCC.
Zeng B; Lin Z; Ye H; Cheng D; Zhang G; Zhou J; Huang Z; Wang M; Cai C; Zeng J; Tang C; Liu J
Cell Physiol Biochem; 2018; 46(3):1122-1133. PubMed ID: 29669339
[TBL] [Abstract][Full Text] [Related]
38. LINC00339 regulates ROCK1 by miR-152 to promote cell proliferation and migration in hepatocellular carcinoma.
Chen K; Zhang L
J Cell Biochem; 2019 Sep; 120(9):14431-14443. PubMed ID: 31081143
[TBL] [Abstract][Full Text] [Related]
39. Knockdown of BDNF suppressed invasion of HepG2 and HCCLM3 cells, a mechanism associated with inactivation of RhoA or Rac1 and actin skeleton disorganization.
Guo D; Sun W; Zhu L; Zhang H; Hou X; Liang J; Jiang X; Liu C
APMIS; 2012 Jun; 120(6):469-76. PubMed ID: 22583359
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-26a suppresses epithelial-mesenchymal transition in human hepatocellular carcinoma by repressing enhancer of zeste homolog 2.
Ma DN; Chai ZT; Zhu XD; Zhang N; Zhan DH; Ye BG; Wang CH; Qin CD; Zhao YM; Zhu WP; Cao MQ; Gao DM; Sun HC; Tang ZY
J Hematol Oncol; 2016 Jan; 9():1. PubMed ID: 26733151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]